Immunization by exposure to live virus (SIV(mne)/HIV-2(287)) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge

por Frenkel, Lisa M., Kuller, LaRene, Beck, Ingrid A., Tsai, Che-Chung, Joy, Jaimy P., Mulvania, Thera M., Hu, Shiu-Lok, Montefiori, David C., Anderson, David M.
Publicado 2021